Antonio Nicolucci , Giacomo Vespasiani , Domenico Mannino , Giuseppina T. Russo , Giuseppe Lucisano , Maria Chiara Rossi , Paola Ponzani , Salvatore De Cosmo , Graziano Di Cianni , Cristina Lencioni , Luca Romeo , Michele Bernardini , Emanuele Frontoni , Riccardo Candido , the EGOAL - AMD Annals Study Group
{"title":"A machine learning algorithm for the prediction of complications incorporated in electronic medical records improves type 2 diabetes care","authors":"Antonio Nicolucci , Giacomo Vespasiani , Domenico Mannino , Giuseppina T. Russo , Giuseppe Lucisano , Maria Chiara Rossi , Paola Ponzani , Salvatore De Cosmo , Graziano Di Cianni , Cristina Lencioni , Luca Romeo , Michele Bernardini , Emanuele Frontoni , Riccardo Candido , the EGOAL - AMD Annals Study Group","doi":"10.1016/j.diabres.2025.112900","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Early identification of patients with type 2 diabetes (T2D) at high risk for complications may help reduce clinical inertia and improve care quality. This study assessed the clinical impact of integrating a machine learning-based prediction tool into electronic medical records (EMRs) in Italian diabetes clinics.</div></div><div><h3>Methods</h3><div>A validated algorithm estimating the 5-year risk of six major diabetes complications was embedded in the EMRs of 38 centers. A pre-post comparison over 12 months was conducted between patients whose risk score was generated (test group) and those eligible but not assessed (control group).</div></div><div><h3>Results</h3><div>Among 138,558 eligible patients, 20,314 (14.7 %) had at least one score generated. Compared to controls, test group patients showed significantly greater improvements in HbA1c ≤7.0 % (+9.0 % vs. +4.5 %), LDL-C <70 mg/dL (+27.9 % vs. +20.7 %), and BMI <25 kg/m<sup>2</sup> (+16.5 % vs. +11.0 %), with larger reductions in HbA1c >8.0 % (–18.4 % vs. –10.1 %). They also more frequently initiated antihypertensive, lipid-lowering, and cardio-renal protective therapies.</div></div><div><h3>Conclusions</h3><div>Embedding an AI-based prediction tool in routine clinical practice improved several quality indicators and therapeutic decisions. Its real-world application shows promise in overcoming clinical inertia and promoting personalized diabetes management.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"229 ","pages":"Article 112900"},"PeriodicalIF":7.4000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725009143","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
Early identification of patients with type 2 diabetes (T2D) at high risk for complications may help reduce clinical inertia and improve care quality. This study assessed the clinical impact of integrating a machine learning-based prediction tool into electronic medical records (EMRs) in Italian diabetes clinics.
Methods
A validated algorithm estimating the 5-year risk of six major diabetes complications was embedded in the EMRs of 38 centers. A pre-post comparison over 12 months was conducted between patients whose risk score was generated (test group) and those eligible but not assessed (control group).
Results
Among 138,558 eligible patients, 20,314 (14.7 %) had at least one score generated. Compared to controls, test group patients showed significantly greater improvements in HbA1c ≤7.0 % (+9.0 % vs. +4.5 %), LDL-C <70 mg/dL (+27.9 % vs. +20.7 %), and BMI <25 kg/m2 (+16.5 % vs. +11.0 %), with larger reductions in HbA1c >8.0 % (–18.4 % vs. –10.1 %). They also more frequently initiated antihypertensive, lipid-lowering, and cardio-renal protective therapies.
Conclusions
Embedding an AI-based prediction tool in routine clinical practice improved several quality indicators and therapeutic decisions. Its real-world application shows promise in overcoming clinical inertia and promoting personalized diabetes management.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.